The person-to-person transmission landscape of the gut and oral microbiomes
The person-to-person transmission landscape of the gut and oral microbiomes - (2023)
Human Microbiome Action Newsletter #1
Find out more about the first Human Microbiome Action newsletter!
The non-selective Rho-kinase inhibitors Y-27632 and Y-33075 decrease contraction but increase migration in murine and human hepatic stellate cells
The non-selective Rho-kinase inhibitors Y-27632 and Y-33075 decrease contraction but increase migration in murine and human hepatic stellate cells - (2023)
Call for Experts – Delphi Survey on Microbiome-based Biomarkers
If you are an expert in microbiome science and [...]
Defining a healthy microbiome and virome – a workshop on microbial functions
The Human Microbiome Action workshop on defining a healthy [...]
Our Microbial Selves – What does it mean to be human?
Microbiome research has the potential to be a major [...]
Updated rules for greater safety and quality of blood, tissues, and cells & microbiome?
Updated rules for greater safety and quality of blood, [...]
Janus kinase 2 inhibition by pacritinib as potential therapeutic target for liver fibrosis
Janus kinase 2 inhibition by pacritinib as potential therapeutic target for liver fibrosis - (2022)
Targeted decrease of portal hepatic pressure gradient improves ascites control after TIPS
Targeted decrease of portal hepatic pressure gradient improves ascites control after TIPS - (2022)
CBMR joins €2M Horizon2020 project to help steer the future of human microbiome research
The Human Microbiome Action consortium will bring more than [...]
